Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Seminars in Neonatology : SN
|
March 6, 2004
Exogenous surfactant therapy: newer developments
Thierry Lacaze-Masmonteil
Clinics in Perinatology
|
March 31, 2007
Expanded use of surfactant therapy in newborns
Thierry Lacaze-Masmonteil
Paediatric Respiratory Reviews
|
October 15, 2013
That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against
Thierry Lacaze-Masmonteil
Paediatrics & Child Health
|
May 18, 2018
Managing infants born to mothers who have used opioids during pregnancy
Thierry Lacaze-Masmonteil, Pat O'Flaherty
Paediatric Drugs
|
September 6, 2003
The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study
Géraldine Lamboley-Gilmert, Thierry Lacaze-Masmonteil,
Paediatrics & Child Health
|
January 9, 2016
Minimizing blood loss and the need for transfusions in very premature infants
Brigitte Lemyre, Megan Sample, Thierry Lacaze-Masmonteil, et al.
Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses
|
November 29, 2012
A single-center experience of implementing delayed cord clamping in babies born at less than 33 weeks' gestational age
Khalid Aziz, Heather Chinnery, Thierry Lacaze-Masmonteil
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
June 24, 2011
Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
Lisa Hartling, Yuanyuan Liang, Thierry Lacaze-Masmonteil
Paediatrics & Child Health
|
June 27, 2019
Neuroprotection from acute brain injury in preterm infants
Michelle Ryan, Thierry Lacaze-Masmonteil, Khorshid Mohammad
Pediatric Pulmonology
|
August 31, 2002
Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis
Thierry Lacaze-Masmonteil, Jean-Christophe Rozé, Brigitte Fauroux, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Seminars in Neonatology : SN
|
March 6, 2004
Exogenous surfactant therapy: newer developments
Thierry Lacaze-Masmonteil
Clinics in Perinatology
|
March 31, 2007
Expanded use of surfactant therapy in newborns
Thierry Lacaze-Masmonteil
Paediatric Respiratory Reviews
|
October 15, 2013
That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against
Thierry Lacaze-Masmonteil
Paediatrics & Child Health
|
May 18, 2018
Managing infants born to mothers who have used opioids during pregnancy
Thierry Lacaze-Masmonteil, Pat O'Flaherty
Paediatric Drugs
|
September 6, 2003
The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study
Géraldine Lamboley-Gilmert, Thierry Lacaze-Masmonteil,
Paediatrics & Child Health
|
January 9, 2016
Minimizing blood loss and the need for transfusions in very premature infants
Brigitte Lemyre, Megan Sample, Thierry Lacaze-Masmonteil, et al.
Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses
|
November 29, 2012
A single-center experience of implementing delayed cord clamping in babies born at less than 33 weeks' gestational age
Khalid Aziz, Heather Chinnery, Thierry Lacaze-Masmonteil
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
June 24, 2011
Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
Lisa Hartling, Yuanyuan Liang, Thierry Lacaze-Masmonteil
Paediatrics & Child Health
|
June 27, 2019
Neuroprotection from acute brain injury in preterm infants
Michelle Ryan, Thierry Lacaze-Masmonteil, Khorshid Mohammad
Pediatric Pulmonology
|
August 31, 2002
Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis
Thierry Lacaze-Masmonteil, Jean-Christophe Rozé, Brigitte Fauroux, et al.
Page
of 8